| Page 19 | Kisaco Research

FLOX AI

I think being honest is important, show where you are today, and the real opportunity you represent for pharma businesses or other players you want to speak to in the room.

Show your social capital and name-drop wisely. Notable investors or clients signal credibility - especially for large corps who might feel you're small.

A significant share of the innovation being funded and developed today is not reaching the animals, clinics, and farms it was designed for. This session brings together voices from across the value chain for an honest conversation about what is breaking in the handoff between innovation and adoption, and what it would take to fix it.

  • The affordability reality: how should founders and funders think about pricing and access from day one?
  • The missing veterinary voice in early-stage decision-making
  • From approval to adoption: where are the biggest bottlenecks?
  • Industry-academia collaboration: what would a better model look like?

Earlier detection and the expanding therapeutic toolkit present great opportunities to improve health outcomes, but this complexity also increases the need for greater collaboration between practice leaders and industry partners.

Innovation does not succeed at approval; it succeeds when it works in the clinic, supports the team and creates sustainable economics for the practice.

Panelists will discuss:

  • How founders and partners can support practice in integrating these innovations into workflows and operations.
  • Helping practice leaders to manage and meet pet owner expectations
  • What are the challenges for founders and industry partners in supporting adoption

Author:

Matt Salois

President
Veterinary Management Groups

Matt Salois

President
Veterinary Management Groups

Author:

Dr Christie Long

Chief Medical Officer
Modern Animal

Dr Christie Long

Chief Medical Officer
Modern Animal